Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

11.10.2018 | short review | Ausgabe 4/2018

memo - Magazine of European Medical Oncology 4/2018

Aggressive variant and treatment-related neuroendocrine prostate cancer: two different terms for the same disease?

memo - Magazine of European Medical Oncology > Ausgabe 4/2018
Igor Tsaur, MD Prof. Christian Thomas


Previously assumed to be rare, the prevalence of aggressive variants of prostate cancer has increased rapidly. This histologically heterogeneous group of cancers, including different forms of the neuroendocrine carcinoma of the prostate, share a common clinical course associated with a poor response to androgen deprivation treatment and fatal prognosis. Currently, the most commonly used terms are aggressive variant of prostate cancer and treatment-related neuroendocrine prostate cancer. The best treatment of these tumors in clinical routine is still being debated. Here, we highlight the clinically most relevant aspects of this heterogeneous disease and summarize recommendations for clinical routine.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Über diesen Artikel

Weitere Artikel der Ausgabe 4/2018

memo - Magazine of European Medical Oncology 4/2018 Zur Ausgabe